FDA Orange Book
Generic for Taytulla
Taytulla contains norethindrone acetate and ethinyl estradiol. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Taytulla is norethindrone acetate and ethinyl estradiol. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Taytulla and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Taytulla products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, oral | 0.02MG;1MG | Marketed (Rx) | AB | 3 | AB |
NDA 204426, held by ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic norethindrone acetate and ethinyl estradiol
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| XIROMED PHARMA ESPANA SL | 213317 | AB (A-rated, therapeutically equivalent) | November 9, 2020 | 0.02MG;1MG |
| WILSHIRE PHARMACEUTICALS INC | 212706 | AB (A-rated, therapeutically equivalent) | December 18, 2020 | 0.02MG;1MG |
| GLENMARK PHARMACEUTICALS LTD | 213418 | AB (A-rated, therapeutically equivalent) | July 27, 2022 | 0.02MG;1MG |
Questions
Is there a generic for Taytulla?
Yes. The generic name for Taytulla is norethindrone acetate and ethinyl estradiol. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Taytulla?
The active ingredient in Taytulla is norethindrone acetate and ethinyl estradiol, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.